potential indications for glp-1 receptor agonists keep expanding are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Oral semaglutide (Rybelsus) is the

We believe these data underscore the potential of CagriSema to address unmet medical needs in obesity and support long-term disease management," said Mike Doustdar, president and CEO of Novo Nordisk

Barnhill RL, Albert LS, Shama SK, et al

Recommended for anyone, athletes, those who suffer from chronic migraines

Safe Charging: Balance Charging Always charge LiPo packs using a balance charger connected to both the main discharge connector and the balance lead (the smaller white JST-XH connector with one wire per cell plus a ground)

Common mutations in the hepatic cholesterol transporter ABCG8 confer most of the genetic risk of developing gallstones, which accounts for 25% of the total risk